News Search Results
Nov 04, 2025, 09:00 ET Kong Releases Insomnia 12 to Accelerate API and MCP Development with AI-Powered Testing and Collaboration
cloud API and AI technologies, announced today the general availability of Insomnia 12, the open source API development platform that unifies designing, mocking, debugging, and testing APIs. The new release focuses on making Insomnia smarter, faster, and more accessible for developers building APIs and Model
More news about: Kong Inc.
Oct 29, 2025, 13:49 ET Marquez Medical Aesthetic Showcasing EXOMIND Technology for Mental and Physical Health
Oct. 29, 2025 /PRNewswire/ -- Individuals seeking a noninvasive treatment for depression, anxiety, obsessive-compulsive disorder, insomnia and brain fog may benefit from EXOMIND, a new brain stimulation treatment now available at Marquez Medical Aesthetic in Hialeah. Research shows EXOMIND
More news about: Marquez Medical Aesthetic
Oct 22, 2025, 08:00 ET Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
stomach (abdominal) pain diarrhea difficulty sleeping (insomnia) back pain hot flashes or hot flushes These are
More news about: Astellas Pharma Inc.
Oct 20, 2025, 21:20 ET SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
dying; attempting to commit suicide; new or worse depression, anxiety, or irritability; feeling agitated or restless; panic attacks; trouble sleeping (insomnia); acting aggressive; being angry or violent; acting on dangerous impulses; an extreme increase in activity and talking (mania); or other unusual changes
More news about: SK Biopharmaceuticals. Co., Ltd.
Oct 20, 2025, 08:00 ET Elektra Health and Oscar Launch HelloMeno the First-Ever Menopause Health Plan in the Individual Market
$0 primary doctor, gynecologist, and behavioral health visits. No-cost labs, hormone replacement therapy, insomnia medications, and bone density scans. 24/7 access to Elektra and a team of doctors who know menopause inside and out2
More news about: Elektra Health
Oct 17, 2025, 08:00 ET Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
(defined as AHI <5 events/hour) AD109 was generally well-tolerated, with the most common adverse events being dry mouth, insomnia and nausea, and no treatment-related serious adverse events were reported Select
More news about: Apnimed, Inc.
Oct 14, 2025, 20:00 ET Astellas to Present First Real-World VEOZAH™ (fezolinetant) Data at 2025 Annual Meeting of The Menopause Society
stomach (abdominal) pain diarrhea difficulty sleeping (insomnia) back pain hot flashes or hot flushes These are
More news about: Astellas Pharma Inc.
Oct 10, 2025, 07:30 ET Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
integrating mental and general health care.12 Insomnia is one of the most common symptoms of MDD, affecting more than 80 percent of people living with MDD.13 Disturbed sleep and insomnia symptoms have a significant impact on a patient's quality of life and exacerbate
More news about: Johnson & Johnson
Oct 07, 2025, 10:40 ET Melatonin Market to Reach USD 3.0 Billion by 2030 as Sleep Health, Supplements, and Clinical Applications Drive Global Demand
Dietary supplements accounted for USD 1.1 billion in 2025, making them the largest revenue driver. Melatonin supplements are widely consumed for insomnia, jet lag, and sleep management, particularly in North America and Asia. Medical industry applications
More news about: DataM Intelligence 4 Market Research LLP
Oct 06, 2025, 08:34 ET Menoveda Announces U.S. Launch
75% of them will experience a range of unpleasant symptoms, from hot flashes to hair loss, anxiety, fatigue, mood swings, insomnia, and brain fog. Menoveda helps alleviate those symptoms, filling a massive and unmet gap in women's health in the process. "We're
More news about: Menoveda
Oct 01, 2025, 07:45 ET Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October
cannabis is not a treatment for cancer, some people living with breast cancer report that cannabis products can help them manage pain, nausea, anxiety, insomnia, and other side effects of treatment. Curaleaf is committed to providing safe, high-quality cannabis options for patients and consumers navigating
More news about: Curaleaf Holdings, Inc.
Sep 30, 2025, 09:00 ET The ADDF's Diagnostics Accelerator Unveils SpeechDx Dataset and New Partnership to Catalyze Breakthroughs in Speech-Based Biomarkers
mental health disorders, as Alzheimer's disease shares many overlapping symptoms with those conditions, such as depression, cognitive decline, and insomnia. Together, we will accelerate the development of tools that can make a real difference in patients' lives."
More news about: Alzheimer's Drug Discovery Foundation
Sep 30, 2025, 08:00 ET Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD)
Symptoms of PPD include hallmarks of major depression, including, but not limited to, sadness, depressed mood, loss of interest, change in appetite, insomnia, sleeping too much, fatigue, difficulty thinking/concentrating, excessive crying, fear of harming the baby/oneself, and/or thoughts of death or suicide.
More news about: Lipocine Inc.
Sep 26, 2025, 10:30 ET Smart Sleep Tracker Market is expected to generate a revenue of USD 68.31 Billion by 2032, Globally, at 12.4% CAGR: Verified Market Research®
health and wellness is driving strong demand for smart sleep trackers. Increasing cases of sleep disorders, stress-related insomnia, and lifestyle diseases are prompting individuals to monitor their sleep patterns.Smart sleep trackers provide actionable insights for better
More news about: Verified Market Research
Sep 25, 2025, 10:44 ET Mental Health Apps Market to Hit US$15.69 Bn by 2033 Amid Rising Wellness Awareness, Says DataM Intelligence Report
and communities acknowledge mental well-being, the demand for accessible digital tools to manage conditions like anxiety, depression, stress, and insomnia continues to rise. This awareness fosters a greater need for effective, user-friendly mental health platforms. Mental health apps serve as
More news about: DataM Intelligence 4 Market Research LLP
Sep 25, 2025, 08:00 ET Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
approval for HETLIOZ® in the treatment of insomnia and Jet Lag Disorder and is continuing to develop HETLIOZ® for the treatment of several other sleep disorders including Delayed Sleep Phase Disorder (DSPD) and pediatric insomnia. References: Synnott NC,
More news about: Vanda Pharmaceuticals Inc.
Sep 24, 2025, 13:18 ET Fusion CBD Products' Sleep and Recovery Softgels Could Help You Conquer Insomnia
Mayo Clinic has outlined ways to combat insomnia and ensure you're getting sufficient sleep. These include: sticking to a sleep schedule to reinforce your body's sleep-wake cycle; avoiding
More news about: Fusion CBD Products
Sep 23, 2025, 09:03 ET Philadelphia Sleep Specialist Dr. Funke Afolabi-Brown Announces Grand Opening Ceremony of The Restful Sleep Place
treatment for sleep disorders including insomnia,
More news about: The Restful Sleep Place
Sep 22, 2025, 08:30 ET Neurocrine Biosciences Presents Positive New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder
3 (6.4) Insomnia 2 (2.2)
More news about: Neurocrine Biosciences, Inc.
Sep 22, 2025, 07:45 ET Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses
patients at recommended doses, one patient reported insomnia following abrupt discontinuation of XYWAV. In the XYWAV clinical trial in adult idiopathic hypersomnia patients at recommended doses, six patients reported insomnia, two patients reported early insomnia, and one patient reported visual and auditory
More news about: Jazz Pharmaceuticals plc
Sep 19, 2025, 11:01 ET Sleep Aids Market to Hit US$ 118.97 Billion by 2033, Growing at 7.8% CAGR - DataM Intelligence
The global sleep aids market is witnessing robust growth, driven by the rising prevalence of sleep disorders such as insomnia, sleep apnea, and restless legs syndrome, along with increasing awareness about the health risks of untreated sleep disturbances. Advances in medications,
More news about: DataM Intelligence 4 Market Research LLP
Sep 18, 2025, 06:45 ET Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection)
disorders. Monitor for signs of perforation and bleeding Acthar may be associated with central nervous system effects ranging from euphoria, insomnia, irritability, mood swings, personality changes, and severe depression to psychosis. Existing conditions may be aggravated Patients with comorbid
More news about: Mallinckrodt plc
Sep 16, 2025, 18:01 ET EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts
further contributed to risk. Adults with suicidal thoughts reported higher levels of stigmatisation and more prevalent sleep disorders, with mixed insomnia – difficulty falling and staying asleep – notably linked to suicidal ideation (OR=1.78). Dr Delphine Kerob, one of the lead researchers, commented,
More news about: European Academy of Dermatology and Venereology (EADV) Congress 2025
Sep 16, 2025, 18:01 ET EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts
further contributed to risk. Adults with suicidal thoughts reported higher levels of stigmatisation and more prevalent sleep disorders, with mixed insomnia – difficulty falling and staying asleep – notably linked to suicidal ideation (OR=1.78). Dr Delphine Kerob, one of the lead researchers, commented,
More news about: European Academy of Dermatology and Venereology (EADV) Congress 2025
Sep 16, 2025, 10:14 ET 5 Surprising Tricks for When You Can't Sleep, a Free Guide to Support Better Rest From Pacific Mind Health
"Sometimes just having a new approach gives you the confidence and calm you need to reset and rest." The free guide arrives at a time when insomnia and disrupted sleep are on the rise. About 50 to 70 million Americans chronically suffer from sleep and wakefulness disorders, according to the Institute
More news about: Pacific Mind Health